Max Healthcare Institute on Tuesday said its profit after tax (PAT) jumped 86 per cent to Rs 320 crore in March quarter 2022-23 on account of improvement in operating metrics in hospitals and reduction in finance costs. The healthcare provider had reported a PAT of Rs 172 crore for January-March 2021-22. Net revenue increased to Rs 1,551 crore in the fourth quarter from Rs 1,224 crore in the year-ago period, Max Healthcare said in a statement. For the year ended March 31, 2023, it posted a PAT of Rs 1,328 crore as compared with Rs 752 crore in 2021-22. Net revenue rose to Rs 5,902 crore in FY23 as compared with Rs 4,981 crore in 2021-22. Max Healthcare Institute Chairman and Managing Director Abhay Soi said the company is actively but prudently evaluating inorganic growth opportunities. The company said its board has approved a final dividend of Re 1 per equity share for the year ended March 31, 2023. Shares of the company ended 2.49 per cent down at Rs 506.90 apiece on the BSE.
Among the new additions to the MSCI Small Cap index, KFIN Technologies, Syrma SGS Technology and Ujjivan Small Finance Bank have rallied up to 6 per cent.
Max says as it has signed a term sheet with Quality Care for the acquisition of Care Hospitals, its offer should be decided first
Stocks to Watch: Shares of aviation firms, such as IndiGo, SpiceJet, Jet Airways, are likely to be in focus on May 03 after Go First filed for insolvency proceeding on Tuesday.
Breach of contract alleged in an offer to acquire Hyderabad-based Care Hospitals
Breach of contract alleged in an offer to acquire Hyderabad-based Care Hospitals
Stocks to Watch: Infosys delivered a weak performance in Q4 as its profit declined 6.9 per cent on a sequential basis, while revenue dropped 2.3 per cent QoQ
Max Healthcare Institute on Thursday reported a 7 per cent increase in its consolidated profit after tax at Rs 269 crore for the December quarter. The healthcare provider had posted a profit after tax of Rs 252 crore in the October-December period of last fiscal. Network gross revenue increased to Rs 1,559 crore, reflecting a 13 per cent year-on-year growth, Max Healthcare said in a statement. "By virtue of focus on healthcare infrastructure, research and skilling as well as ground breaking policies such as National Digital Healthcare Mission, Heal In India and Heal By India, the government has established a solid foundation to enable the private sector players in India to cater to both domestic and global requirements at affordable prices," Max Healthcare Institute Chairman and MD Abhay said. Shares of the company ended 0.23 per cent down at Rs 440.4 apiece on the BSE.
The growth in Q2FY23 revenue and operating EBITDA were driven by higher occupancies, improved payor mix, and increased ARR in OPD.
Max Healthcare on Tuesday reported an over three-fold rise in its consolidated net profit for the second quarter to Rs 457.35 crore, as against Rs 144.65 crore in the year-ago period. The healthcare provider's revenue from operations stood at Rs 1,137.12 crore during the July-September period, up from Rs 1,019.26 crore, a regulatory filing showed. Its total expenses also increased to Rs 897.72 crore during the quarter under review, as against Rs 860.09 crore in the year-ago period. Abhay Soi, Chairman and MD, Max Healthcare Institute Ltd, said: "The performance for Q2 FY23 is as per our expectations and reflects the focus on execution across the organisation in line with our articulated strategy. Healthcare sector in general and Max Healthcare in particular are making significant investments over the next 4-5 years leading to huge employment opportunities and a multiplier effect on GDP." He added that the impetus provided by the government through its focus on healthcare and 'heal
International patient revenues up 16% during quarter, 110% of pre-Covid average; PAT grows 29% on like-to-like basis
Several hospital players are on an expansion spree, as things are getting better for them after the Covid lull. Will the aggressive expansion cycle help the sector achieve sustainable growth ahead?
A CCI investigation showed that higher pricing was charged for renting rooms, medicines, tests, medical devices, and consumables. In some hospitals, the room rents exceeded charges of 4-star hotels
KKR sold the entire 26.8% stake worth Rs 9,400 cr as part of its exit strategy
CLOSING BELL: Maruti Suzuki, M&M, Asian Paints, HUL, Ultratech Cement, Tech M, and HDFC twins were the top gainers on the Sensex index
State-owned insurance behemoth Life Insurance Corporation (LIC) reported a net profit of Rs 682.88 crore in the April-June quarter (Q1) of FY23, driven by its non-par business.
American PE major exits from hospital chain after acquiring the stake in 2018
'Q1FY23 performance reflects normalisation of revenues and operating EBITDA post Omicron wave in the previous quarter,' Max Healthcare Chairman and MD Abhay Soi said in a statement
Average stake down 40 bps from previous quarter at 22%
Max Healthcare Institute on Wednesday said its profit after tax increased by 58 per cent to Rs 172 crore for the fourth quarter ended March 2022. The company had reported a net profit of Rs 109 crore for the January-March quarter of 2020-21 fiscal. Gross revenue rose to Rs 1,298 crore for the period under review as compared with Rs 1,161 crore in the year-ago period, Max Healthcare Institute said in a regulatory filing. For the year ended March 31, 2022, the healthcare provider posted a net profit of Rs 837 crore. It had reported a net loss of Rs 95 crore in FY21 fiscal. "Overall, FY22 has been an eventful year where despite numerous challenges, there is a marked improvement in the network performance," Max Healthcare Institute Chairman and MD Abhay Soi said in a statement. As part of the company's inorganic growth strategy, it has announced four transactions, including purchase of two prime land parcels in Gurugram, he noted. "These will have a combined potential to add 2,200 be